Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


 

Facebook's new hire sparks IPO rumors

Mon. June 29, 2009; Posted: 08:36 PM
Stocks RSS
Jun 29, 2009 (San Jose Mercury News - McClatchy-Tribune Information Services via COMTEX) -- DNA | Quote | Chart | News | PowerRating -- Tech business tea-leaves readers were sent a-Twittering today that Facebook either is -- or isn't -- gearing up for a Wall Street debut following the appointment of a new chief financial officer who spent 15 years at Genentech.

"Facebook Sets the Stage for IPO with New CFO," declared the Web-business news site Mashable -- a headline that Facebook said was highly premature.

The appointment of former Genentech CFO David Ebersman should not be interpreted as a signal that Facebook is gearing up for an initial public offering of stock, said Facebook spokesman Larry Yu.

"We're focused on building a company for the long-term," Yu said. Ebersman's experience "at one of the most respected companies in the world," he added, "will be invaluable as he partners with others on the management team to help take the company to the next level."

That "next level" was widely interpreted in March as an IPO after Facebook founder and CEO Mark Zuckerberg told employees in a internal memo he was seeking a CFO with "public company experience" following the dismissal of former CFO Gideon Yu. The comment struck some observers as odd, since Yu had public company experience, though not at the CFO level.

With more than 200 million users worldwide, Facebook figures to someday launch a high-profile IPO that could prove lucrative even in a frigid economy.

Speculation declined with a recent $200 million investment from Russia's DST Technologies,

a deal that valued the company at $10 billion. DST also expressed an interest in increasing its 1.96 percent stake by acquiring more equity from vested shareholders, a plan that could reduce internal pressures for an IPO from employees eager to convert private stock and options into cash.

Ebersman, 39, has never led a startup through an IPO. "But since we have no imminent plans to go public, such experience is really of secondary concern," Yu said.

Genentech went public in 1980, long before Ebersman joined the biotech pioneer. He worked there for 15 years, starting as a business development analyst and moving up to the title of CFO and executive vice president from 2006 through April 2009, when Roche Group acquired the South San Francisco company in a $46.8 billion deal.

Ebersman adds to a brain trust of seasoned Silicon Valley executives advising the precocious Zuckerberg, who was just 19 when he founded Facebook in early 2004. In early 2008, Facebook hired former Google executive Sheryl Sandberg as its chief operating officer, and more recently added serial entrepreneur Marc Andreessen -- known for Netscape, Opsware and Ning -- to its board of directors.

Facebook met with "many impressive candidates," Zuckerberg said in a press release. "We quickly recognized that David was the right person for Facebook. He was Genentech's CFO while revenue tripled, and his success in scaling the finance organization of a fast growing company will be important to Facebook."

One Twitter user, meanwhile, felt compelled to quip about a Genentech-Facebook alliance: "Only a matter of time before they replace your friends with clones."

Scott Duke Harris can be reached at sdharris@mercurynews.com or 408-920-2704.

To see more of the San Jose Mercury News, or to subscribe to the newspaper, go
to http://www.mercurynews.com. Copyright (c) 2009, San Jose Mercury News, Calif.
Distributed by McClatchy-Tribune Information Services. For reprints, email
tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax
to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave.,
Suite 303, Glenview, IL 60025, USA.
For full details for DNA click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [DNA]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.